Silence Therapeutics plc Share Price
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Cboe BZX
12:21:09 22/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 13.30 USD | +0.95% |
|
-2.92% | +119.08% |
| 18/08 | European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading | MT |
| 13/08 | European Equities Traded in the US Rise in Thursday Trading | MT |
| Market Cap | 58Cr 79Cr 68Cr 63Cr 109.08Cr 7.58TCr 110.53Cr 750.21Cr 292.56Cr 3.81TCr 297.48Cr 291.01Cr 13TCr | P/E 2026 * |
-19.5x | P/E 2027 * | -16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 45Cr 61Cr 52Cr 49Cr 84Cr 5.84TCr 85Cr 578.43Cr 225.57Cr 2.94TCr 229.36Cr 224.37Cr 9.71TCr | EV / Sales 2026 * |
1,380x | EV / Sales 2027 * | 543x |
| Free-Float |
69.35% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Silence Therapeutics plc
| 1 day | +0.95% | ||
| 1 week | -2.92% | ||
| Current month | +26.98% | ||
| 1 month | +22.76% | ||
| 3 months | +105.24% | ||
| 6 months | +164.29% | ||
| Current year | +119.08% |
| 1 week | 13.01 |  | 14.59 |
| 1 month | 10.32 | | 17.58 |
| Current year | 4.19 | | 17.58 |
| 1 year | 4.19 | | 17.58 |
| 3 years | 1.97 | | 27.72 |
| 5 years | 1.97 | | 27.72 |
| 10 years | 1.97 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 01/12/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 01/02/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 21/06/2018 |
Iain Ross
CHM | Chairman | 72 | 01/01/2004 |
Tim McInerney
BRD | Director/Board Member | 65 | 05/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/07/26 | Sell | 8,65,112 | 0.6105% | |||
| 02/01/26 | Free | Chief Financial Officer | 3,75,000 | 0.2646% | ||
| 02/01/26 | Free | Director | 90,000 | 0.0635% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.95% | -2.92% | +143.96% | +90.56% | 79Cr | |
| +1.09% | +5.26% | +4.44% | +26.03% | 5.12TCr | |
| -2.01% | +1.69% | +467.87% | +593.54% | 4.54TCr | |
| +2.19% | +8.46% | +20.04% | +92.17% | 4.2TCr | |
| +0.86% | +8.85% | +38.95% | +20.17% | 4.21TCr | |
| -0.93% | -4.80% | +17.39% | +46.60% | 3.19TCr | |
| +0.20% | +2.78% | - | - | 1.67TCr | |
| +1.94% | +8.17% | +38.03% | +154.40% | 1.71TCr | |
| +0.03% | +3.41% | +7.12% | +35.49% | 1.48TCr | |
| +1.14% | +5.46% | +91.11% | +47.00% | 1.39TCr | |
| Average | +0.55% | +2.30% | +92.10% | +122.88% | 2.76TCr | |
| Weighted average by Cap. | +0.42% | +3.10% | +102.75% | +148.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3L 4L 4L 4L 6L 4.23Cr 6L 41.91L 16.34L 2.13Cr 16.62L 16.26L 7.04Cr | 8L 10.23L 9L 8L 14.09L 9.79Cr 14.27L 96.87L 37.78L 4.92Cr 38.41L 37.58L 16Cr |
| Net income | -4.14Cr -5.65Cr -4.84Cr -4.53Cr -7.78Cr -540.54Cr -7.88Cr -53Cr -21Cr -271.54Cr -21Cr -21Cr -898.13Cr | -6.63Cr -9.03Cr -7.74Cr -7.24Cr -12Cr -864.38Cr -13Cr -86Cr -33Cr -434.22Cr -34Cr -33Cr -1.44TCr |
| Net Debt | -13Cr -18Cr -16Cr -15Cr -25Cr -1.74TCr -25Cr -171.78Cr -67Cr -871.91Cr -68Cr -67Cr -2.88TCr | -17Cr -24Cr -20Cr -19Cr -33Cr -2.27TCr -33Cr -224.63Cr -88Cr -1.14TCr -89Cr -87Cr -3.77TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/26/22 | $13.33 | +1.21% | 3,15,575 |
| 20/26/20 | $13.17 | -3.23% | 5,85,256 |
| 19/26/19 | $13.61 | -3.48% | 9,77,258 |
| 18/26/18 | $14.10 | -1.74% | 14,87,596 |
| 17/26/17 | $14.35 | +4.59% | 10,02,276 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Select your edition
All financial news and data tailored to specific country editions
